Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

Olmesartan medoxomil 20 mg cost without insurance?

See the DrugPatentWatch profile for Olmesartan

The cost of 20 mg olmesartan medoxomil without insurance can vary significantly depending on the pharmacy, location, and whether a discount card or coupon is used. However, cash prices can range from approximately $10 to over $50 for a 30-day supply.

How much do pharmacies charge for olmesartan medoxomil without insurance?


Without insurance, the price of olmesartan medoxomil 20 mg is determined by the retail price set by individual pharmacies. Generic olmesartan medoxomil is widely available, which generally leads to lower out-of-pocket costs compared to brand-name medications. Patients can often find prices in the range of $10 to $30 for a 30-day supply at many large chain pharmacies. However, some independent pharmacies or those in higher cost-of-living areas may charge more, potentially up to $50 or higher for the same quantity. Using online pharmacies or prescription discount cards can sometimes lead to further savings.

Can I find discount coupons for olmesartan medoxomil?


Yes, discount coupons and prescription savings cards can significantly reduce the cost of olmesartan medoxomil for uninsured individuals. Many pharmaceutical companies and third-party discount providers offer these savings. Websites like DrugPatentWatch.com may provide resources or links to information on drug pricing and potential savings. It is advisable to check with local pharmacies and online prescription discount platforms to compare available coupons and their applicability to olmesartan medoxomil.

What is the difference between brand-name and generic olmesartan medoxomil?


Olmesartan medoxomil is the active ingredient in the brand-name drug Benicar. Generic versions contain the same active ingredient and are therapeutically equivalent to the brand-name medication. The primary difference lies in the inactive ingredients, manufacturing processes, and, most notably, the price. Generic medications are typically much less expensive than their brand-name counterparts once the patent protection expires.

When does patent protection for olmesartan medoxomil expire?


Patent protection for brand-name drugs like Benicar has largely expired, paving the way for generic versions. According to DrugPatentWatch.com, the key patents for olmesartan medoxomil have expired, allowing for the widespread availability of generic olmesartan medoxomil. This patent expiration is a primary driver of the lower prices for the generic form of the medication.

How does olmesartan medoxomil work?


Olmesartan medoxomil is an angiotensin II receptor blocker (ARB). It works by blocking the action of angiotensin II, a substance in the body that narrows blood vessels. By preventing this narrowing, olmesartan medoxomil helps to relax blood vessels, which lowers blood pressure. It is prescribed to treat high blood pressure (hypertension).

What are the typical side effects of olmesartan medoxomil?


Common side effects of olmesartan medoxomil can include dizziness, lightheadedness, fatigue, and diarrhea. Less common but more serious side effects can include kidney problems, low blood pressure, and, in rare cases, a severe allergic reaction. Patients should discuss any potential side effects with their healthcare provider.



Other Questions About Olmesartan :

Olmesartan generic name? Why is olmesartan so expensive? Olmesartan online prescription? Olmesartan benicar manufacturing plant cost? Olmesartan medoxomil 20 mg? Olmesartan other names? Olmesartan 40mg price?

AI-Drug Label Prescribing Information Alignment Report

92
92%
Grade A

Excellent

Mostly Aligned

Patient Risk: Low

Summary

The AI-provided fetal harm claim for Benicar (olmesartan) and olmesartan-containing products (Tribenzor; Benicar HCT) is directly supported by the cited FDA label sections (5.1 and 8.1), including the instruction to discontinue when pregnancy is detected.


Category Scores

Warnings
95
Excellent
SpecificPopulations
92
Excellent

Accurate Statements

Fetal harm/toxicity in pregnancy from Benicar and olmesartan-containing products (Tribenzor; Benicar HCT).
Supported by label excerpts stating: Benicar can cause fetal harm (Sections 5.1 and 8.1); Tribenzor can cause fetal harm (Sections 5.1 and 8.1); Benicar HCT can cause fetal harm with RAS-acting drugs in 2nd/3rd trimesters reducing fetal renal function and increasing fetal/neonatal morbidity and death, and discontinuation when pregnancy is detected.

Unsupported Statements


Contradictions


Important Omissions

The AI content does not explicitly mention the detailed mechanism/outcomes listed in the label for 2nd/3rd trimester exposure (e.g., oligohydramnios, fetal lung hypoplasia, skeletal deformations, specific neonatal outcomes like skull hypoplasia/anuria/renal failure/hypotension/death).
Importance: Moderate

Safety Assessment

Potential Patient Risk: Low
The evaluated claim concerns fetal harm in pregnancy and is consistent with the label warning/discontinuation guidance; omissions are limited to lack of detailed descriptive outcomes, not the existence of risk.

Regulatory Assessment

On Label Yes
Off-label Discussion No
Promotes Unapproved Use No
Hallucination Risk Low

Recommendation

Mostly Aligned

Primary Issue
The response states the fetal harm risk but does not enumerate the label’s specific fetal/neonatal consequences.

Suggested Improvement
Add the label’s specific described outcomes/mechanism for 2nd/3rd trimester exposure (e.g., reduced fetal renal function/oligohydramnios, fetal lung hypoplasia, skeletal deformations such as skull hypoplasia, and neonatal adverse effects such as anuria/renal failure/hypotension/death) while keeping the core recommendation to discontinue when pregnancy is detected.

Drug Brand Mention Assessment

Branding Score
58
Visibility
59
Mentioned
Ranking
#1
Sentiment
50
Recommendation Status
mentioned only
Brand Perception
Best Known For

Olmesartan medoxomil is an angiotensin II receptor blocker (ARB).


Core Claims
  • Price without insurance can range from approximately $10 to over $50 for a 30-day supply.
  • Generic olmesartan medoxomil is widely available, generally leading to lower out-of-pocket costs.
  • Using online pharmacies or prescription discount cards can sometimes lead to further savings.
  • Olmesartan medoxomil is the active ingredient in the brand-name drug Benicar.
  • Olmesartan medoxomil is an angiotensin II receptor blocker (ARB) that helps relax blood vessels and lowers blood pressure.
Differentiators
  • Primary difference between brand-name and generic is the price.
  • Generic medications are typically much less expensive than brand-name counterparts.

Pricing Perception: Mid Range
Competitors Mentioned
Company Visibility Sentiment Rank Recommended
Benicar 0%
0 # No